In a press release dated December 21, 2024, Zinzino announced that the company has finalized an agreement to acquire the assets of Zurvita, a direct-selling healthcare company, after serving as a debtor-in-possession (DIP) financier during Zurvita’s Chapter 11 bankruptcy proceedings.
Zinzino provided DIP financing totaling USD 4.5 million, and following the successful completion of the restructuring process, its offer to acquire Zurvita’s assets has been accepted as part of a debt-settled purchase arrangement. The final terms of the acquisition have now been agreed upon by both parties.
Under the agreement, Zinzino will pay a fixed purchase price of USD 9.4 million, which includes the DIP financing. Of this amount, USD 2.5 million will be settled through newly issued Zinzino shares.
Additionally, the acquisition includes contingent earn-out payments based on sales performance from 2025 to 2029, with a maximum additional consideration of USD 1.9 million, which will also be fully settled in newly issued Zinzino shares. The cash portion of the purchase price will be financed through Zinzino’s existing cash reserves.
Zurvita operates in the United States, Canada, and Mexico, offering a diverse portfolio of innovative health and wellness products. Through this acquisition, Zinzino will gain access to Zurvita’s distribution network, inventory, intellectual property